27508328|t|Laparoscopic Approach for Thermoablation Microwave in the Treatment of Hepatocellular Carcinoma: A Single Center Experience
27508328|a|The surgical therapy of choice for hepatocellular carcinoma (HCC) is liver transplantation (LT) or hepatic resection, although only a small percentage of patients can undergo these procedures. Microwave thermal ablation (MWTA) can be an effective alternative treatment for HCC that complicates a cirrhotic liver disease, either as a final procedure or for downstaging patients on the waiting list for LT, or in combination with resective surgery to achieve oncological radicality. The purpose of this retrospective study was to evaluate experience with the laparoscopic approach of MWTA at our center. In a cohort of 35 consecutive patients undergoing MWTA with laparoscopic approach between January, 2013 and May, 2016, we reviewed the demographic data, the Barcelona clinic liver cancer stage, the severity of cirrhotic liver disease, the size of the ablated lesion, the duration of the procedure, and complications occurring within 90 days of surgery. MWTA was performed by applying one to three hepatic parenchymal insertions (mean 1.8) per patient. The mean duration of surgery was 163 Â± 18 minutes. There was no blood loss in any of the procedures. Complete necrosis on CT scan was achieved in 26/35 patients (75%). The mean hospital stay was 4.6 (range 2-7) days; major complications were postablation syndrome in 2/35 (5.7%), peritoneal fluid in 4/35 (11.4%), and transient jaundice in 1/35 (2.8%) patients. There was no mortality. Laparoscopic MWTA is a safe and effective treatment for unresectable HCC and when a percutaneous procedure is not feasible.
27508328	0	21	Laparoscopic Approach	T060	C0031150
27508328	26	50	Thermoablation Microwave	T061	C3854551
27508328	58	67	Treatment	T061	C0087111
27508328	71	95	Hepatocellular Carcinoma	T191	C2239176
27508328	113	123	Experience	T041	C0596545
27508328	128	144	surgical therapy	T061	C0543467
27508328	159	183	hepatocellular carcinoma	T191	C2239176
27508328	185	188	HCC	T191	C2239176
27508328	193	214	liver transplantation	T061	C0023911
27508328	216	218	LT	T061	C0023911
27508328	223	240	hepatic resection	T061	C0400440
27508328	258	263	small	T081	C0700321
27508328	264	274	percentage	T081	C0439165
27508328	278	286	patients	T101	C0030705
27508328	305	315	procedures	T169	C2700391
27508328	317	343	Microwave thermal ablation	T061	C3854551
27508328	345	349	MWTA	T061	C3854551
27508328	361	370	effective	T080	C1280519
27508328	371	382	alternative	T077	C1523987
27508328	383	392	treatment	T061	C0087111
27508328	397	400	HCC	T191	C2239176
27508328	406	417	complicates	T169	C0231242
27508328	420	443	cirrhotic liver disease	T047	C0023890
27508328	457	462	final	T079	C3853528
27508328	463	472	procedure	T169	C2700391
27508328	480	491	downstaging	T060	C0430022
27508328	492	500	patients	T101	C0030705
27508328	525	527	LT	T061	C0023911
27508328	535	546	combination	T080	C0205195
27508328	552	561	resective	T061	C0015252
27508328	562	569	surgery	T061	C0543467
27508328	581	592	oncological	T191	C0027651
27508328	593	603	radicality	T080	C0439807
27508328	625	644	retrospective study	T062	C0035363
27508328	652	660	evaluate	T058	C0220825
27508328	661	671	experience	T041	C0596545
27508328	681	702	laparoscopic approach	T060	C0031150
27508328	706	710	MWTA	T061	C3854551
27508328	731	737	cohort	T098	C0599755
27508328	744	755	consecutive	T080	C1707491
27508328	756	764	patients	T101	C0030705
27508328	776	780	MWTA	T061	C3854551
27508328	786	807	laparoscopic approach	T060	C0031150
27508328	861	877	demographic data	T062	C0011289
27508328	883	918	Barcelona clinic liver cancer stage	T185	C3899974
27508328	924	932	severity	T080	C0439793
27508328	936	959	cirrhotic liver disease	T047	C0023890
27508328	965	969	size	T082	C0456389
27508328	977	984	ablated	T061	C0547070
27508328	985	991	lesion	T033	C0221198
27508328	997	1005	duration	T079	C0449238
27508328	1013	1022	procedure	T169	C2700391
27508328	1028	1041	complications	T169	C0231242
27508328	1062	1066	days	T079	C0439228
27508328	1070	1077	surgery	T061	C0543467
27508328	1079	1083	MWTA	T061	C3854551
27508328	1123	1130	hepatic	T029	C0205054
27508328	1131	1142	parenchymal	T024	C4277702
27508328	1143	1153	insertions	T058	C0441587
27508328	1155	1159	mean	T081	C0444504
27508328	1169	1176	patient	T101	C0030705
27508328	1182	1186	mean	T081	C0444504
27508328	1187	1195	duration	T079	C0449238
27508328	1199	1206	surgery	T061	C0543467
27508328	1220	1227	minutes	T079	C0439232
27508328	1242	1252	blood loss	T033	C3163616
27508328	1267	1277	procedures	T169	C2700391
27508328	1288	1296	necrosis	T042	C0027540
27508328	1300	1307	CT scan	T060	C0040405
27508328	1330	1338	patients	T101	C0030705
27508328	1350	1354	mean	T081	C0444504
27508328	1355	1368	hospital stay	T079	C3489408
27508328	1389	1393	days	T079	C0439228
27508328	1401	1414	complications	T169	C0231242
27508328	1420	1432	postablation	T079	C1292448
27508328	1433	1441	syndrome	T047	C0039082
27508328	1458	1474	peritoneal fluid	T031	C0003964
27508328	1496	1505	transient	T079	C0205374
27508328	1506	1514	jaundice	T047	C0022354
27508328	1530	1538	patients	T101	C0030705
27508328	1550	1562	no mortality	T033	C0243095
27508328	1564	1576	Laparoscopic	T060	C0031150
27508328	1577	1581	MWTA	T061	C3854551
27508328	1596	1605	effective	T080	C1280519
27508328	1606	1615	treatment	T061	C0087111
27508328	1620	1632	unresectable	T201	C1519810
27508328	1633	1636	HCC	T191	C2239176
27508328	1648	1660	percutaneous	T082	C0522523
27508328	1661	1670	procedure	T169	C2700391